High levels of MCL1 were found in solid human tumors and cell lines derived from human leukemia or lymphomas [10]; furthermore, studies in vivo showed that knockdown of NOXA or co-expression of MCL1 and oncogene MYC can significantly accelerate the development of tumors such as lymphoma or leukemia [10-12]. This evidence concerns the gene PMAIP1 and lymphoma.